Healthcare provider profile · identity verified

Roxana P Viera, MD

Family Practice · JUPITER, FL · NPI 1730140054

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	632	223
Losartan Potassium	Losartan Potassium	475	151
Atorvastatin Calcium	Atorvastatin Calcium	434	154
Amlodipine Besylate	Amlodipine Besylate	381	138
Levothyroxine Sodium	Levothyroxine Sodium	291	103
Metoprolol Succinate	Metoprolol Succinate	226	75
Lisinopril	Lisinopril	207	70
Omeprazole	Omeprazole	201	82
Metformin Hcl	Metformin Hcl	198	79
Alendronate Sodium	Alendronate Sodium	191	70
Gabapentin	Gabapentin	186	72
Trazodone Hcl	Trazodone Hcl	153	66
Albuterol Sulfate Hfa	Albuterol Sulfate	152	72
Simvastatin	Simvastatin	152	54
Pantoprazole Sodium	Pantoprazole Sodium	135	53
Hydrochlorothiazide	Hydrochlorothiazide	133	46
Escitalopram Oxalate	Escitalopram Oxalate	132	44
Furosemide	Furosemide	124	42
Valsartan	Valsartan	117	43
Sertraline Hcl	Sertraline Hcl	110	40
Ozempic	Semaglutide	101	19
Clopidogrel	Clopidogrel Bisulfate	99	32
Diclofenac Sodium	Diclofenac Sodium	97	54
Azithromycin	Azithromycin	95	82
Eliquis	Apixaban	94	26
Clonazepam	Clonazepam	91	21
Fluticasone Propionate	Fluticasone Propionate	88	56
Montelukast Sodium	Montelukast Sodium	84	28
Tamsulosin Hcl	Tamsulosin Hcl	76	30
Famotidine	Famotidine	73	37
Potassium Chloride	Potassium Chloride	72	26
Mirtazapine	Mirtazapine	71	29
Methylprednisolone	Methylprednisolone	69	60
Jardiance	Empagliflozin	68	27
Allopurinol	Allopurinol	64	22
Duloxetine Hcl	Duloxetine Hcl	64	21
Alprazolam	Alprazolam	63	14
Atenolol	Atenolol	61	23
Carvedilol	Carvedilol	59	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	39
Metoprolol Tartrate	Metoprolol Tartrate	57	20
Meloxicam	Meloxicam	55	28
Prednisone	Prednisone	54	41
Zolpidem Tartrate	Zolpidem Tartrate	53	11
Citalopram Hbr	Citalopram Hydrobromide	51	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	46	42
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	45	39
Pravastatin Sodium	Pravastatin Sodium	43	15
Triamcinolone Acetonide	Triamcinolone Acetonide	43	27
Fluoxetine Hcl	Fluoxetine Hcl	42	16
Breo Ellipta	Fluticasone/Vilanterol	40	12
Finasteride	Finasteride	40	16
Labetalol Hcl	Labetalol Hcl	38	13
Nystatin	Nystatin	38	29
Spironolactone	Spironolactone	38	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Synthroid	Levothyroxine Sodium	37	16
Bupropion Xl	Bupropion Hcl	36	16
Buspirone Hcl	Buspirone Hcl	36	16
Januvia	Sitagliptin Phosphate	36	15
Levofloxacin	Levofloxacin	36	33
Estradiol	Estradiol	34	14
Nifedipine Er	Nifedipine	34	12
Paroxetine Hcl	Paroxetine Hcl	34	11
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	11
Tizanidine Hcl	Tizanidine Hcl	32	11
Metformin Hcl Er	Metformin Hcl	31	14
Cephalexin	Cephalexin	30	28
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	26
Celecoxib	Celecoxib	28	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	11
Cefdinir	Cefdinir	27	24
Lactulose	Lactulose	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	15
Temazepam	Temazepam	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	16
Fluconazole	Fluconazole	19	14
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	14
Amoxicillin	Amoxicillin	18	14
Ciclopirox	Ciclopirox	18	12
Donepezil Hcl	Donepezil Hcl	17	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	11
Myrbetriq	Mirabegron	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	12
Ezetimibe	Ezetimibe	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Ketoconazole	Ketoconazole	14	11
Pregabalin	Pregabalin	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Bupropion Hcl	Bupropion Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	12
Mupirocin	Mupirocin	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error